Edesa Biotech Gross Margin Growth & History (EDSA)

Edesa Biotech's gross margin was 94.65% for fiscal 2020.

View full Edesa Biotech company overview

Edesa Biotech annual gross margin history

Edesa Biotech annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20202020-09-3094.65%+19.30 pp
20192019-09-3075.35%
20172017-09-30−400.08%−435.72 pp
20162016-09-3035.63%+12.19 pp
20152015-09-3023.44%
20142014-08-31−26.07%−115.56 pp
20132013-08-3189.49%+138.52 pp
20122012-08-31−49.03%

Edesa Biotech gross margin trends

Over the last five fiscal years, Edesa Biotech's gross margin increased from 23.44% to 94.65%, a change of +71.20 percentage points. The latest reported quarter, Q4 2020, shows −362.80%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Edesa Biotech source filings ↗

Community posts

It’s quiet here.

No posts about EDSA yet. Start the conversation.

Write the first post